- $448.75m
- $545.98m
- $526.52m
Brief: Core Laboratories Says On July 17, Co Terminated Equity Distribution Agreement Dated June 9, 2022
Core Laboratories NV reports results for the quarter ended in March - Earnings Summary
Brief: Core Lab Reports First Quarter 2023 Results
Brief: Core Laboratories NV - QTRLY Revenue Of $128 Million Up 11% Year-Over-Year
Core Laboratories NV expected to post earnings of 16 cents a share - Earnings Preview
Core Laboratories NV reports results for the quarter ended in December - Earnings Summary
Brief: Core Laboratories Provides Q1 Outlook
Core Laboratories NV expected to post earnings of 20cents a share - Earnings Preview
Insight: Venezuela exports oil, despite US sanctions, using false documents, ships linked to Iran
Core Laboratories NV reports results for the quarter ended in September - Earnings Summary
Brief: Core Lab Reports Third Quarter 2022 Results From Continuing Operations
Core Laboratories NV expected to post earnings of 15cents a share - Earnings Preview
Core Laboratories NV reports results for the quarter ended in June - Earnings Summary
Brief: Core Laboratories NV - Q2 GAAP EPS $0.15
Brief: Core Laboratories Says Amended Credit Agreement To Reduce Aggregate Borrowing Commitment To $135 Mln From $225 Mln
Core Laboratories NV expected to post earnings of 14 cents a share - Earnings Preview
NYSE ORDER IMBALANCE 178534.0 SHARES ON SELL SIDE
Brief: Core Lab Announces $60 Mln At-The-Market Equity Offering Program
NYSE ORDER IMBALANCE 84667.0 SHARES ON BUY SIDE